Penn Medicine 2020 Updates in Oncology
Managing mNSCLC Patients With a Molecular Target: How Promising Are New RET & MET Inhibitors?
By
Penn Medicine 2020 Updates in Oncology
FEATURING
Joshua Bauml
By
Penn Medicine 2020 Updates in Oncology
FEATURING
Joshua Bauml
Login to view comments.
Click here to Login